Analysis of Polymorphic Membrane Protein Expression in Cultured Cells Identifies PmpA and PmpH of Chlamydia psittaci

Sarah Van Lent1, Winnok H De Vos2,3, Heather Huot Creasy4

  • 1Department of Animal Production, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.

Plos One
|September 16, 2016
PubMed

Insights

Polymorphic membrane proteins (Pmps) of Chlamydia psittaci, particularly PmpA and PmpH, are highly produced and accessible, suggesting their potential as vaccine targets for Chlamydia infections.

Area of Science:

  • Microbiology
  • Immunology
  • Veterinary Medicine

Background:

  • Polymorphic membrane proteins (Pmps) are key targets for Chlamydia vaccine development.
  • The role of Pmps in Chlamydia psittaci pathogenesis and vaccine potential is largely unexplored.

Purpose of the Study:

  • To investigate the expression, production, and localization of C. psittaci Pmps.
  • To assess the potential of C. psittaci Pmps as vaccine candidates.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) for transcription analysis.
  • Immunofluorescence (IF) and immuno-electron microscopy (IEM) for protein localization and accessibility.
  • Analysis under normal and stress conditions.

Main Results:

  • PmpA was highly produced early in infection (12 hpi).
  • PmpA and PmpH showed unusual accessibility to antibodies.
  • Expression profiles varied under different conditions.

Conclusions:

  • PmpA and PmpH play significant roles in C. psittaci pathogenesis.
  • These Pmps are promising candidates for Chlamydia vaccine development.